Piezo1 affects several fundamental pathophysiological processes in glioblastoma, such as tissue sclerosis, angiogenesis, energy supply, and immune cell infiltration, and can be used as an indicator of malignancy and prognosis in patients with glioblastoma, as well as a therapeutic target to control tumor progression. Here, PIEZO1 is linked to glioblastoma.